Innovation and Patent Law Reform: Hearings Before the Subcommittee on Courts, Civil Liberties, and the Administration of Justice of the Committee on the Judiciary, House of Representatives, Ninety-eighth Congress, Second Session, on H.R. 3285, H.R. 3286, and H.R. 3605 ... March 28, April 26, and June 6, 27, 1984, 3. daļaU.S. Government Printing Office, 1985 - 2897 lappuses |
No grāmatas satura
1.–5. rezultāts no 73.
940. lappuse
... Medicine letter to Hon . Robert W. Kastenmeier , dated November 21 , 1983 .. ( 26 ) ... Drug Testing and Approval Prior to Expiration of Patent on Brand Name Drug ... Application and Patent Term Restoration Act .. 1003 ( 44 ) Fitzpatrick ...
... Medicine letter to Hon . Robert W. Kastenmeier , dated November 21 , 1983 .. ( 26 ) ... Drug Testing and Approval Prior to Expiration of Patent on Brand Name Drug ... Application and Patent Term Restoration Act .. 1003 ( 44 ) Fitzpatrick ...
948. lappuse
... Drug Price Competition and Patent Term Restoration Act of 1984 Dear Mr. Chairman : I am patent counsel to the ... applications for extensions would actually be processed despite its title 948.
... Drug Price Competition and Patent Term Restoration Act of 1984 Dear Mr. Chairman : I am patent counsel to the ... applications for extensions would actually be processed despite its title 948.
950. lappuse
... drug companies that the issuance of patents for non - commer- cialized products would spur the investment necessary to develop these products . See Application of Anthony 414 F.2d 1383 ( CCPA 1969 ) . The issuance of a patent on a drug ...
... drug companies that the issuance of patents for non - commer- cialized products would spur the investment necessary to develop these products . See Application of Anthony 414 F.2d 1383 ( CCPA 1969 ) . The issuance of a patent on a drug ...
952. lappuse
... approval to engage in competition immediately after that well - defined monopoly period ended . The parties ... drug patent owners . The Commissioner's disregard for the fairness of the ... Application Date : Patent No. Patent Holder : DA 952.
... approval to engage in competition immediately after that well - defined monopoly period ended . The parties ... drug patent owners . The Commissioner's disregard for the fairness of the ... Application Date : Patent No. Patent Holder : DA 952.
953. lappuse
... Application Date : Patent No. Patent Holder : DA Approval Date : Issue Date : ASNICATIO : FOR PATENT DOTSION ( DRUG PRODUCT OR USE PATENT ) Expiration Date : Assignment Recorded : Reel Frame NDA Submission Date : IND Filing Date ...
... Application Date : Patent No. Patent Holder : DA Approval Date : Issue Date : ASNICATIO : FOR PATENT DOTSION ( DRUG PRODUCT OR USE PATENT ) Expiration Date : Assignment Recorded : Reel Frame NDA Submission Date : IND Filing Date ...
Saturs
946 | |
954 | |
977 | |
984 | |
1019 | |
1041 | |
1134 | |
1142 | |
1435 | |
1482 | |
1577 | |
1612 | |
1656 | |
1657 | |
1660 | |
1663 | |
1145 | |
1147 | |
1183 | |
1206 | |
1207 | |
1215 | |
1221 | |
1245 | |
1284 | |
1294 | |
1307 | |
1335 | |
1341 | |
1672 | |
1680 | |
1725 | |
1739 | |
1756 | |
1786 | |
1824 | |
1835 | |
1855 | |
1867 | |
1886 | |
1888 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
1962 Amendments 2d Cir Adkins ANDA antitrust approved drug available as prior Bass benefits beta blockers bill Bolar challenge successful Circuit claims clinical testing commercial companies company/client Consent Judgment constitutional contract Corp costs decision or settlement defendant Dextrose diazepam disclosed disclosure district court DOSAGE FORM drug application drug products estoppel federal filing firms Hoffmann-La Roche I.V. Solution industry Injection innovation invalid inventor Labs Lear doctrine legislation license licensee estoppel licensor litigation manufacture monopoly NAME TRADE NAME NCEs NDAS APPROVED patent application patent infringement patent issues patent law Patent Office patent owner patent protection patent rights patent system patent term patent term restoration patent validity period pharmaceutical plaintiff preliminary injunction prior art prior invention proposed question reduced to practice regulation relief Roche royalties Sodium Sodium Chloride statutory Supp supra note Tablet tion trade secret United vaccine Zenith